Clinical Characteristics of Diabetic Patients with Initial and Recurrent Foot Ulcers

GONG Hong-ping, REN Yan, ZHA Pan-pan, LI Yan, Raju Bista, GAO Yun, CHEN Da-wei, RAN Xing-wu, WANG Chun

Abstract

To explore the risk factors for the recurrence of foot ulcers by analyzing clinical characteristics of the patients with diabetic foot ulcers (DFU) in West China Hospital, Sichuan University.  Methods  A retrospective analysis was carried out with the clinical data of 817 DFU patients hospitalized at West China Hospital, Sichuan University between January 1, 2012 and December 31, 2020. The patients were divided into an initial ulceration group (502 cases) and a recurrent ulceration group (315 cases) according to their history of foot ulcers. The differences in clinical characteristics between the two groups were compared, and multivariate logistic regression analysis was conducted to identify the risk factors associated with the recurrence of foot ulcers.   Results  Initial and recurrent DFU patients both had predominantly neuro-ischemic foot ulcers, and the most common sites of ulceration were the first and fifth toes in both groups. Compared with the initial DFU group, more patients in the recurrent group had foot ulcers of Wagner grade 3 and ulcerous wounds located on calluses (P<0.05), and fewer patients in the recurrent group suffered from foot gangrene (P<0.05). Patients with recurrent DFU had lower glycated hemoglobin, platelet counts, and fibrinogen levels (P<0.05), and higher serum uric acid and creatinine levels (P<0.05). Hemoglobin, white blood cell count, estimated glomerular filtration rate, erythrocyte sedimentation rate and C-reactive protein levels were not significantly different between the two groups (P>0.05). Multivariable logistic regression analysis showed that male sex (OR=1.555, 95% CI: 1.097-2.204, P=0.013), duration of diabetes≥10 years (OR=2.369, 95% CI: 1.473-3.810, P<0.001), history of amputation (OR=4.518, 95% CI: 2.386-8.553, P<0.001), foot osteoporosis (OR=1.711, 95% CI: 1.065 to 2.751, P=0.027), ulcerous wound located on foot callus (OR=1.786, 95% CI: 1.058-3.012, P=0.030), and coronary heart disease (OR=0.668, 95% CI:0.453-0.987, P=0.043) were significantly associated with the recurrence of foot ulcers.   Conclusions  Male sex, duration of diabetes being over 10 years, history of previous amputation, foot osteoporosis, and ulcerous wounds located on foot callus are independent risk factors of recurrent foot ulcers in patients with DFU. Therefore, even after their foot ulcers have healed, special attention should be given to the care of foot for patients with DFU, which may reduce the recurrence of foot ulcers.

 

Keywords: Diabetic foot ulcers, Recurrent foot ulcers, Foot callus, Causes of foot ulcers, Risk factors

 

Full Text:

PDF


References


ZHANG P， LU J， JING Y， et al. Global epidemiology of diabetic foot ulceration: A systematic review and meta-analysis. Ann Med，2017，49(2): 106–116.

ARMSTRONG D G， BOULTON A J M， BUS S A. Diabetic foot ulcers and their recurrence. N Engl J Med，2017，376(24): 2367–2375.

JIANG Y， WANG X， XIA L， et al. A cohort study of diabetic patients and diabetic foot ulceration patients in China. Wound Repair Regen， 2015，23(2): 222–230.

ÖRNEHOLM H， APELQVIST J， LARSSON J， et al. Recurrent and other new foot ulcers after healed plantar forefoot diabetic ulcer. Wound Repair Regen，2017，25(2): 309–315.

BUS S A， LAVERY L A， MONTEIRO-SOARES M， et al. Guidelines on the prevention of foot ulcers in persons with diabetes (IWGDF 2019 update). Diabetes Metab Res Rev， 2020， 36 (Suppl 1): e3269[2022-07-22]. https://doi.org/10.1002/dmrr.3269.

VAN NETTEN J J， BUS S A， APELQVIST J， et al. Definitions and criteria for diabetic foot disease. Diabetes Metab Res Rev， 2020， 36(Suppl 1): e3268[2022-07-22]. https://doi.org/10.1002/dmrr.3268.

HINCHLIFFE R J， FORSYTHE R O， APELQVIST J， et al. Guidelines on diagnosis， prognosis， and management of peripheral artery disease in patients with foot ulcers and diabetes (IWGDF 2019 update). Diabetes Metab Res Rev， 2020， 36(Suppl 1): e3276[2022-07-22]. https://doi.org/ 10.1002/dmrr.3276.

HUANG Z H， LI S Q， KOU Y， et al. Risk factors for the recurrence of diabetic foot ulcers among diabetic patients: A meta-analysis. Int Wound J，2019，16(6): 1373–1382.

PETERS E J， ARMSTRONG D G， LAVERY L A. Risk factors for recurrent diabetic foot ulcers: Site matters. Diabetes Care，2007，30(8): 2077–2079.

GIRACH A， MANNER D， PORTA M. Diabetic microvascular complications: Can patients at risk be identified? A review. Int J Clin Pract，2006，60(11): 1471–1483.

CHENG Y， ZU P， ZHAO J， et al. Differences in initial versus recurrent diabetic foot ulcers at a specialized tertiary diabetic foot care center inChina. J Int Med Res，2021，49(1): 300060520987398.

APELQVIST J， LARSSON J， AGARDH C D. Long-term prognosis for diabetic patients with foot ulcers. J Intern Med，1993，233(6): 485–491.

CHALYA P L， MABULA J B， DASS R M， et al. Surgical management of diabetic foot ulcers: A Tanzanian university teaching hospital experience. BMC Res Notes， 2011， 4: 365[2022-07-22]. https://doi.org/10.1186/1756-0500-4-365.

QUEBEDEAUX T L， LAVERY L A， LAVERY D C. The development of foot deformities and ulcers after great toe amputation in diabetes. Diabetes Care，1996，19(2): 165–167.

MOLINES-BARROSO R J， LÁZARO-MARTÍNEZ J L， ÁLVARO-AFONSO F J， et al. Validation of an algorithm to predict reulceration in amputation patients with diabetes. Int Wound J，2017，14(3): 523–528.

BITENC-JASIEJKO A， KONIOR K， GONTA K， et al. Prophylaxis of pain and fractures within feet in the course of osteoporosis: The issue of diagnosing. Pain Res Manag， 2020， 2020: 1391026[2022-10-04]. https://doi.org/10.1155/2020/1391026.

DAVIS F M， KIMBALL A， BONIAKOWSKI A， et al. Dysfunctional wound healing in diabetic foot ulcers: New crossroads. Curr Diab Rep， 2018，18(1): 2.

FREEMAN D B. Corns and calluses resulting from mechanical hyperkeratosis. Am Fam Physician，2002，65(11): 2277–2280.

BUS S A， VAN NETTEN J J， HINCHLIFFE R J， et al. Standards for the development and methodology of the 2019 International Working Group on the Diabetic Foot guidelines. Diabetes Metab Res Rev， 2020， 36 Suppl 1(Suppl1): e3267[2022-07-22]. https://doi.org/10.1002/dmrr.3267.

ULBRECHT J S， HURLEY T， MAUGER D T， et al. Prevention of recurrent foot ulcers with plantar pressure-based in-shoe orthoses: the CareFUL prevention multicenter randomized controlled trial. Diabetes Care，2014，37(7): 1982–1989.

PETERSEN B J， ROTHENBERG G M， LAKHANI P J， et al. Ulcer metastasis? Anatomical locations of recurrence for patients in diabetic foot remission. J Foot Ankle Res， 2020， 13: 1[2022-07-22]. https://doi. org/10.1186/s13047-020-0369-3.

GALEA A M， SPRINGETT K， BUNGAY H， et al. Incidence and location of diabetic foot ulcer recurrence. Diabetic Foot J，2009，12(4): 181–186.


Refbacks

  • There are currently no refbacks.